-
The Chinese Influence at EHA: Dr. He Huang’s Team Presents Multiple Studies, Offering New Insights into Bone Marrow Transplantation and CAR-T Therapy
The 29th European Hematology Association (EHA) Annual Meeting was successfully held in Madrid, Spain, from June 13 to 16, 2024. As the largest international conference in the field of hematology in Europe, it annually attracts experts and scholars from around the world to share and discuss innovative ideas and the latest scientific and clinical research…
-
EHA 2024丨Bright Future Ahead: Key Developments in Luspatercept Treatment for Lower-Risk MDS Interpreted by Dr. Chungkang Chang
The European Hematology Association (EHA) annual meeting, one of the most influential international academic conferences in the field of hematology, gathers numerous experts and scholars worldwide every year. The aim is to share and deeply discuss innovative ideas and the latest scientific and clinical research advancements in hematology, thereby promoting continuous progress in the field.…
-
Dr. Libo Zhao: Advances in TDM Practices for Anti-Infective Drugs at Home and Abroad丨IDSC 2024
Editor’s Note: Antimicrobial drugs play a crucial role in clinical treatment, essential for controlling infectious diseases caused by various pathogens, including bacteria, mycoplasma, and chlamydia. However, inappropriate use of these…
-
Dr. Baiyi Chen: Key Elements in Early Empirical Treatment of Invasive Candidiasis
Editor’s Note: Candidiasis presents with a wide range of clinical manifestations, among which invasive candidiasis poses significant risks, leading to longer hospital stays, increased healthcare costs, and higher mortality rates.…
-
Dr. Sujun Zheng: Advances in the Diagnosis and Treatment of Inactive HBsAg Carriers
According to estimates from the Polaris Observatory, the prevalence of inactive hepatitis B surface antigen (HBsAg) carriers in the general population in China was 6.1% in 2016, with approximately 86 million people chronically infected with HBV. This suggests that around 36.08% of these individuals are inactive HBsAg carriers (IHC), equating to about 30.96 million people.…
-
AIDS Dialogue | Breakthroughs in HIV Treatment: In-Depth Discussion on Integrase Inhibitors, Weight Management, and Prevention Strategies
With continuous advancements in technology and deepening research in the field of AIDS prevention, new breakthroughs in HIV treatment and management have emerged. During the 25th International AIDS Conference, “Infectious Diseases Frontier” invited Dr. Hui Wang from Shenzhen Third People’s Hospital and Dr. Huachun Zou from the Fudan University School of Public Health for an in-depth dialogue. They shared the…
-
SIFIC: Leading with Wisdom, Embracing Openness and Innovation
Recently, the 20th Shanghai International Forum for Infection Control (SIFIC) and the 8th Oriental Forum on Complex Infectious Diseases (OFCID), along with the Annual Academic Meeting of the Global Chinese Clinical Microbiology and Infectious Diseases Society, were successfully held in Shanghai. Infectious Diseases Frontier had the privilege of interviewing several administrators of the SIFIC forum…
-
Dr. Davide Rossi: The Role of Liquid Biopsy (ctDNA) in the Diagnosis and Treatment of Malignant Lymphoma
In the field of lymphoma diagnosis and treatment, traditional methods such as tissue biopsy, while valuable, are increasingly showing limitations due to their invasive nature, inconvenience in repeated sampling, and inability to fully reflect tumor heterogeneity. Liquid biopsy, as an emerging non-invasive testing technology, is demonstrating great potential in the diagnosis and treatment of lymphoma.…
Connecting Medical Expertise through Media